Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 21:14:11-17.
doi: 10.2147/CPAA.S344268. eCollection 2022.

Antileishmanial Activity of Tamoxifen by Targeting Sphingolipid Metabolism: A Review

Kaleab Alemayehu Zewdie  1 , Haftom Gebregergs Hailu  1 , Muluken Altaye Ayza  1 , Bekalu Amare Tesfaye  1
Affiliations
Review

Antileishmanial Activity of Tamoxifen by Targeting Sphingolipid Metabolism: A Review

Kaleab Alemayehu Zewdie et al. Clin Pharmacol. .

Abstract

Leishmaniasis is a widespread group of neglected parasitic diseases caused by protozoa of the genus Leishmania. Around 2 million new cases are reported each year and around 12 million people are at risk of being infected. Although various therapies have been used to treat leishmaniasis, they have been associated with increased cytotoxicity and drug resistance problems. Hence, the present review was intended to show the potential of tamoxifen as an alternative option for the treatment of leishmaniasis. Tamoxifen is a known selective estrogen receptor modulator and has been widely used for the treatment of early-stage breast cancer. Various experimental and clinical studies revealed that it has an antileishmanial effect by decreasing parasitic burden, with low cost and few side effects. The antileishmanial action of tamoxifen has been related to its potential effect on sphingolipid metabolism. Besides, it affects mitochondrial function by inducing alterations in the plasma membrane potential. However, further detailed studies are required to show the ultimate effects on health outcomes.

Keywords: estrogen receptor modulator; leishmaniasis; sphingolipid metabolism; tamoxifen.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest for this work.

References

    1. Pace D. Leishmaniasis. J Infect. 2014;69(Suppl 1):S10–8. doi:10.1016/j.jinf.2014.07.016 - DOI - PubMed
    1. Regina S, Soares DC, Hirata CF. Cell death mechanisms in Leishmania amazonensis triggered by methylene blue-mediated antiparasitic photodynamic therapy. Photodiagnosis Photodyn Ther. 2018. doi:10.1016/j.pdpdt.2018.05.005 - DOI - PubMed
    1. Tabbabi A. Review of Leishmaniasis in the Middle East and North Africa. Afr Health Sci. 2019;19:1329–1337. doi:10.4314/ahs.v19i1.4 - DOI - PMC - PubMed
    1. Celes FS, Trovatti E, Khouri R, et al. DETC-based bacterial cellulose bio-curatives for topical treatment of cutaneous leishmaniasis. Sci Rep. 2016;6:1–11. doi:10.1038/srep38330 - DOI - PMC - PubMed
    1. Jawed J, Majumdar S. Recent Trends in Leishmania Research: a Therapeutic Perspective. J Infect. 2018;1:1–4. doi:10.29245/2689-9981/2018/3.1120 - DOI